The Mechanism
Regenerating Joints From Within
Osteoarthritis and joint injuries involve progressive degradation of cartilage, synovial membrane inflammation, and loss of joint space. Conventional treatments manage symptoms. Exosome therapy addresses the underlying cellular environment.
iPSC exosomes deliver chondrogenic signals that stimulate chondrocyte survival, reduce pro-inflammatory cytokines (TNF-α, IL-1β), and promote the synthesis of type II collagen — the structural protein of cartilage.
- Reduces synovial inflammation within 2–4 weeks
- Stimulates chondrocyte proliferation and cartilage matrix synthesis
- Inhibits MMPs (enzymes that degrade cartilage)
- Promotes subchondral bone health
- Significant pain reduction reported in 70–80% of patients
